Market News
Namita Thapar's Emcure Pharmaceuticals IPO - Key insights & details
By Gauri Singh
4m 34s | Updated on July 02, 2024, 13:20 IST
SUMMARY
Emcure Pharmaceuticals, India's 13th largest pharma company by domestic sales, plans an IPO from July 3-5, 2024. The ₹1,952.03 crore issue includes ₹800 crore fresh issue and ₹1,152.03 crore offer for sale, mainly for debt repayment.
Emcure Pharmaceuticals, incorporated in 1981, develops, manufactures and markets a wide range of pharma products. In this video, we cover details about the company and its IPO!
About The Author
Gauri Singh is an anchor and journalist with over a decade of experience, currently covering business, finance and general news. Beyond her professional pursuits as a storyteller, she is a cricket fan, loves travelling and is a dedicated yoga practitioner.
Next Story
